RU2000124880A - METHODS AND DEVICES FOR IMMUNE RESPONSE MODULATION - Google Patents
METHODS AND DEVICES FOR IMMUNE RESPONSE MODULATIONInfo
- Publication number
- RU2000124880A RU2000124880A RU2000124880/14A RU2000124880A RU2000124880A RU 2000124880 A RU2000124880 A RU 2000124880A RU 2000124880/14 A RU2000124880/14 A RU 2000124880/14A RU 2000124880 A RU2000124880 A RU 2000124880A RU 2000124880 A RU2000124880 A RU 2000124880A
- Authority
- RU
- Russia
- Prior art keywords
- specified
- antigen
- mammal
- polymeric material
- porous matrix
- Prior art date
Links
- 230000028993 immune response Effects 0.000 title claims 10
- 230000000051 modifying Effects 0.000 title claims 5
- 239000000427 antigen Substances 0.000 claims 38
- 102000038129 antigens Human genes 0.000 claims 38
- 108091007172 antigens Proteins 0.000 claims 38
- 239000000463 material Substances 0.000 claims 36
- 241000124008 Mammalia Species 0.000 claims 24
- 239000011159 matrix material Substances 0.000 claims 20
- 238000002513 implantation Methods 0.000 claims 10
- 210000002865 immune cell Anatomy 0.000 claims 9
- 102000008186 Collagen Human genes 0.000 claims 8
- 108010035532 Collagen Proteins 0.000 claims 8
- 229920001436 collagen Polymers 0.000 claims 8
- 229960005188 collagen Drugs 0.000 claims 8
- 229920001577 copolymer Polymers 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 210000004408 Hybridomas Anatomy 0.000 claims 6
- 229920002689 polyvinyl acetate Polymers 0.000 claims 6
- 239000011118 polyvinyl acetate Substances 0.000 claims 6
- 102000005614 monoclonal antibodies Human genes 0.000 claims 5
- 108010045030 monoclonal antibodies Proteins 0.000 claims 5
- 229920000747 poly(lactic acid) polymer Polymers 0.000 claims 5
- 239000004626 polylactic acid Substances 0.000 claims 5
- 239000011248 coating agent Substances 0.000 claims 4
- 238000000576 coating method Methods 0.000 claims 4
- 230000002068 genetic Effects 0.000 claims 4
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 claims 3
- 108010010803 Gelatin Proteins 0.000 claims 3
- 210000004027 cells Anatomy 0.000 claims 3
- 229920000159 gelatin Polymers 0.000 claims 3
- 239000008273 gelatin Substances 0.000 claims 3
- 235000019322 gelatine Nutrition 0.000 claims 3
- 235000011852 gelatine desserts Nutrition 0.000 claims 3
- 230000036039 immunity Effects 0.000 claims 3
- 229920002635 polyurethane Polymers 0.000 claims 3
- 239000004814 polyurethane Substances 0.000 claims 3
- 210000000987 Immune System Anatomy 0.000 claims 2
- 229920000126 Latex Polymers 0.000 claims 2
- 210000004698 Lymphocytes Anatomy 0.000 claims 2
- 239000004698 Polyethylene (PE) Substances 0.000 claims 2
- 239000004793 Polystyrene Substances 0.000 claims 2
- 229960000070 antineoplastic Monoclonal antibodies Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 229920001971 elastomer Polymers 0.000 claims 2
- 230000003053 immunization Effects 0.000 claims 2
- 239000004816 latex Substances 0.000 claims 2
- 229960000060 monoclonal antibodies Drugs 0.000 claims 2
- 229920000058 polyacrylate Polymers 0.000 claims 2
- -1 polyethylene Polymers 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- 229920001296 polysiloxane Polymers 0.000 claims 2
- 229920002223 polystyrene Polymers 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- 239000005060 rubber Substances 0.000 claims 2
- 230000001629 suppression Effects 0.000 claims 2
- 238000002255 vaccination Methods 0.000 claims 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 claims 1
- 206010003816 Autoimmune disease Diseases 0.000 claims 1
- 210000003719 B-Lymphocytes Anatomy 0.000 claims 1
- 229920002676 Complementary DNA Polymers 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 208000002491 Severe Combined Immunodeficiency Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- 201000005794 allergic hypersensitivity disease Diseases 0.000 claims 1
- 230000001413 cellular Effects 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 229920003013 deoxyribonucleic acid Polymers 0.000 claims 1
- 238000009792 diffusion process Methods 0.000 claims 1
- 230000004727 humoral immunity Effects 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 230000001939 inductive effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000011886 peripheral blood Substances 0.000 claims 1
- 230000002035 prolonged Effects 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
Claims (57)
а) введения лимфоцитов периферической крови человека в кровоток мыши с тяжелым комбинированным иммунодефицитом (SCID) и предоставление указанным лимфоцитам возможности заселить иммунную систему указанной мыши;
b) имплантации устройства по п. 21 указанной мыши, причем антиген указанного устройства включает в себя предварительно выбранный антиген;
c) сбора иммунных клеток из указанного устройства;
а) приготовления гибридом на основе В лимфоцитов, присутствующих среди указанных собранных иммунных клеток; и
е) идентификации с помощью методики скрининга тех гибридом, которые продуцируют моноклональные антитела, узнающие указанный предварительно выбранный антиген.51. A method of producing hybridomas producing human monoclonal antibodies against a preselected antigen, comprising the sequential steps
a) injecting human peripheral blood lymphocytes into the bloodstream of a severe combined immunodeficiency mouse (SCID) and enabling said lymphocytes to colonize the immune system of said mouse;
b) implanting a device according to claim 21 of said mouse, wherein the antigen of said device includes a preselected antigen;
c) collecting immune cells from said device;
a) preparing hybridomas on the basis of B lymphocytes present among these assembled immune cells; and
e) identifying, by screening, those hybridomas that produce monoclonal antibodies that recognize the indicated preselected antigen.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3340298A | 1998-03-02 | 1998-03-02 | |
US09/033,402 | 1998-03-02 | ||
US25992999A | 1999-03-01 | 1999-03-01 | |
US09/259,929 | 1999-03-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2000124880A true RU2000124880A (en) | 2002-08-20 |
RU2225197C2 RU2225197C2 (en) | 2004-03-10 |
Family
ID=26709654
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2000124880/15A RU2225197C2 (en) | 1998-03-02 | 1999-03-02 | Method and device for modulating immune response |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040166141A1 (en) |
EP (1) | EP1066028A2 (en) |
JP (1) | JP2003523308A (en) |
KR (1) | KR20010041528A (en) |
CN (1) | CN1299272A (en) |
AU (1) | AU756951B2 (en) |
HU (1) | HUP0101076A2 (en) |
ID (1) | ID26963A (en) |
NO (1) | NO20004349L (en) |
PL (1) | PL343432A1 (en) |
RU (1) | RU2225197C2 (en) |
TR (1) | TR200003225T2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2432556T3 (en) | 2004-08-04 | 2013-12-04 | Evonik Corporation | Methods for manufacturing supply devices and their devices |
US8728528B2 (en) | 2007-12-20 | 2014-05-20 | Evonik Corporation | Process for preparing microparticles having a low residual solvent volume |
TW201034641A (en) * | 2009-02-28 | 2010-10-01 | Charles Knezevich | Apparatus, system, and method for creating immunologically enhanced spaces in-vivo |
EP2596802A1 (en) * | 2011-11-23 | 2013-05-29 | PLS-Design GmbH | Pharmaceutical composition for treatment of allergic reactions |
CN103479400A (en) * | 2012-06-11 | 2014-01-01 | 浙江我武生物科技股份有限公司 | Dermatitis diagnostic patch containing urushiol and preparation method of dermatitis diagnostic patch |
WO2018067813A1 (en) * | 2016-10-05 | 2018-04-12 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for augmenting immune system responses |
WO2018144099A1 (en) | 2016-11-03 | 2018-08-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Methods and systems for real-time assessment of cells in encapsulation devices pre-and post-transplantation |
WO2018144098A1 (en) | 2016-11-03 | 2018-08-09 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Stacked tissue encapsulation device systems with or without oxygen delivery |
WO2018085714A1 (en) | 2016-11-03 | 2018-05-11 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Encapsulation device systems with oxygen sensors with or without exogenous oxygen delivery |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4687001A (en) * | 1977-02-14 | 1987-08-18 | The United States Of America As Represented By The Department Of Health And Human Services | Subcutaneous fluid and culture chamber and implant technique |
US4919929A (en) * | 1984-02-01 | 1990-04-24 | Stolle Research & Development Corporation | Mammal immunization |
ATE87215T1 (en) * | 1987-07-21 | 1993-04-15 | Stolle Res & Dev | METHOD OF OBTAINING IMMUNO-REGULATORY FACTORS USING MAMMALIAN IMMUNIZATION. |
NZ242065A (en) * | 1991-03-26 | 1996-06-25 | Csl Ltd | Delayed release implant having a degradable or rupturable polymeric coating |
US5538733A (en) * | 1994-07-07 | 1996-07-23 | Willmar Poultry Company, Inc. | Method of priming an immune response in a one-day old animal |
-
1999
- 1999-03-02 JP JP2000534186A patent/JP2003523308A/en active Pending
- 1999-03-02 ID IDW20001980A patent/ID26963A/en unknown
- 1999-03-02 AU AU30667/99A patent/AU756951B2/en not_active Ceased
- 1999-03-02 CN CN99805765A patent/CN1299272A/en active Pending
- 1999-03-02 PL PL99343432A patent/PL343432A1/en not_active Application Discontinuation
- 1999-03-02 HU HU0101076A patent/HUP0101076A2/en unknown
- 1999-03-02 KR KR1020007009699A patent/KR20010041528A/en not_active Application Discontinuation
- 1999-03-02 EP EP99912252A patent/EP1066028A2/en not_active Withdrawn
- 1999-03-02 RU RU2000124880/15A patent/RU2225197C2/en active
- 1999-03-02 TR TR2000/03225T patent/TR200003225T2/en unknown
-
2000
- 2000-09-01 NO NO20004349A patent/NO20004349L/en not_active Application Discontinuation
-
2004
- 2004-02-20 US US10/783,052 patent/US20040166141A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5674289A (en) | Bioartificial pancreas | |
CN1080130C (en) | In vitro conea equivalent model | |
US5891455A (en) | Process for producing an implant from cell cultures | |
US5387237A (en) | Bioartificial pancreas | |
US5653756A (en) | Closed porous chambers for implanting tissue in a host | |
US5453278A (en) | Laminated barriers for tissue implants | |
US5545223A (en) | Ported tissue implant systems and methods of using same | |
US5593440A (en) | Tissue implant systems and methods for sustaining viable high cell densities within a host | |
US4604346A (en) | Skin-equivalent prepared by the use of punch biopsy | |
US6773458B1 (en) | Angiogenic tissue implant systems and methods | |
JP4162378B2 (en) | Penis reconstruction | |
US5916554A (en) | Use of pouch for implantation of living cells | |
JPH06507412A (en) | Implantable and biocompatible immunoblocking vehicles for the release of selected therapeutic substances | |
JPH04507051A (en) | Artificial pancreas perfusion device | |
RU2000124880A (en) | METHODS AND DEVICES FOR IMMUNE RESPONSE MODULATION | |
JP2002531123A5 (en) | ||
BR9908466A (en) | Process to modulate the immune response, in a mammal, to an antigen, implantable device to modulate an immune response to an antigen, and, processes to obtain immune cells from a mammal, for immunization of a mammal with an antigen, for the production of hybridomas producing human monoclonal antibodies against a pre-selected antigen, to transfect a mammal's immune cells with genetic material, and for the treatment or prophylaxis of a disease or condition caused by an immune response | |
CN1299272A (en) | Method and device for modulating the immune response | |
Ersek et al. | Processed bovine cartilage: an improved biosynthetic implant for contour defects | |
Villa et al. | Residual heteroantigenicity of glutaraldehyde‐treated porcine cardiac valves | |
SU1364988A1 (en) | Method of producing bola-type serums | |
Widner | Immunological basis for intracerebral reconstructive transplantations. | |
RU2032739C1 (en) | Method of optimal time selection of endocrine organ cells cultivation designed for transplantation | |
WO1996039100A1 (en) | Tissue loading system for implantable biological devices | |
Whitehead | Anti-antibodies and Anti-idiotype Immunoregulation, 1899–1904 |